New approved uses of antineoplastic agents during the COVID-19 pandemic in Colombia- Part 1: Oral antineoplastic agents, cytotoxic agents, and monoclonal antibodies excluding immune checkpoint inhibitors.

← Return to Article Details

Sistema OJS 3.4.0.7 - Metabiblioteca |